Canis ISSN: 2398-2942

Pancuronium

Contributor(s): John Dodam, Vetstream Ltd

Introduction

Name

  • Pancuronium.

Class of drug

  • Non-depolarizing neuromuscular blocking agent.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Profound skeletal muscle relaxation when modest cardiovascular stimulation required.
  • In patients undergoing mechanical ventilation.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmacokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

Drugs which may antagonize the effects of pancuronium

Suxamethonium

  • May enhance muscular relaxation (delay the administration of pancuronium until the effects of suxamethonium begin to diminish) Suxamethonium.

Drugs which may enhance the action of pancuronium

  • Some antibiotics, eg aminoglycosides, clindamycin Clindamycin , lincomycin Lincomycin.
  • Inhalational anesthetics, eg halothane Halothane , methoxyflurane Methoxyflurane.
    Duration of action is longer when isoflurane Isoflurane rather than halothane is used to maintain anethesia.
  • Magnesium salts.
  • Quinidine Quinidine.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

Other sources of information

  • Ramsey I (2017) BSAVA Small Animal Formulary. 9th edn. 
  • Based on Small Animal Formulary. Tennant, Bryn (1999) 3rd edn. Cheltenham: BSAVA.

ADDED